Follow-on osteoporosis therapy after denosumab discontinuation among Medicare beneficiaries. Sendhil SR, Cadarette SM, Aggarwal S, Oganisian A, et al. Osteoporos Int 2025 Oct 27. doi: 10.1007/s00198-025-07668.

Read + Share

Amedeo Smart

Independent Medical Education

Sendhil SR, Cadarette SM, Aggarwal S, Oganisian A, et al. Follow-on osteoporosis therapy after denosumab discontinuation among Medicare beneficiaries. Osteoporos Int 2025 Oct 27. doi: 10.1007/s00198-025-07668.
PMID: 41143882